1. Home
  2. DLY vs MPLT Comparison

DLY vs MPLT Comparison

Compare DLY & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Yield Opportunities Fund of Beneficial Interest

DLY

DoubleLine Yield Opportunities Fund of Beneficial Interest

HOLD

Current Price

$14.70

Market Cap

705.8M

Sector

Finance

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$17.30

Market Cap

822.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLY
MPLT
Founded
2019
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
705.8M
822.2M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
DLY
MPLT
Price
$14.70
$17.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$31.00
AVG Volume (30 Days)
215.9K
338.9K
Earning Date
01-01-0001
02-28-2026
Dividend Yield
8.93%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.26
$12.24
52 Week High
$15.95
$21.55

Technical Indicators

Market Signals
Indicator
DLY
MPLT
Relative Strength Index (RSI) 52.39 N/A
Support Level $14.67 N/A
Resistance Level $14.92 N/A
Average True Range (ATR) 0.09 0.00
MACD 0.01 0.00
Stochastic Oscillator 53.33 0.00

Price Performance

Historical Comparison
DLY
MPLT

About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest

DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: